RFK Jr. Launches Government Autism Registry Using Private Health Data

Government Autism Registry Initiative

• 🎯 The Trump administration is reportedly establishing a government-run autism registry.
• 💡 This registry will be populated using a wide range of private medical data, including records from pharmacies, insurance companies, labs, the VA, and potentially wearable devices.
• 🔑 The initiative is being spearheaded by Robert F. Kennedy Jr., who is described as the Secretary of Health and Human Services.

Data Sources and Access

• 🔍 The registry aims to collect genomics records, Medicaid data, and prescription history to build a comprehensive database.
• 🔒 A select group of researchers will be granted access to study the data, with the stated limitation that they cannot download it.
• ⚠️ This process is characterized as medical surveillance of a vulnerable population without public consent or scientific integrity.

RFK Jr.'s Stance on Autism and Vaccines

• 🧠 Robert F. Kennedy Jr. has previously claimed that autism is preventable and has floated the idea of curing it.
• 🚫 He is also noted for attempting to revive the debunked link between vaccines and autism, referencing the retracted study by Dr. Andrew Wakefield.
• 📈 The CDC, under Kennedy's influence, is reportedly investigating the vaccine-autism link again in 2025.

Potential Consequences and Precedents

• 📉 A potential outcome is that autism diagnoses may appear to decline, not due to actual reduction, but because parents fear testing their children due to potential government retaliation or insurance discrimination.
• 🚩 This tactic could be used by RFK Jr. and Trump to claim victory in reducing autism rates by removing vaccine requirements, a formula described as manufacturing a crisis and then claiming credit for a manufactured solution.
• ⚖️ The creation of an autism registry sets a precedent for potential government surveillance of other conditions, such as ADHD, depression, or gender identity issues.
• 📊 The rise in diagnoses is attributed by critics to improved diagnostic tools, similar to how mammograms increased breast cancer detection, rather than an actual increase in the condition's prevalence.